Oral iloprost treatment in patients with
โ
Fredrick M. Wigley; Joseph H. Korn; M. E. Csuka; Thomas A. Medsger Jr.; Naomi F.
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 876 KB
## Objective: To evaluate the efficacy and tolerability of an oral preparation of iloprost, a prostacyclin analog, in patients with raynaud's phenomenon (rp) secondary to systemic sclerosis (scleroderma). ## Methods: A multicenter, randomized, parallel-group, placebo-controlled double-blind study